Press Release: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline.
Press Release: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN - Newscast
Fri, 02 May 2025 14:02:00 GMT WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NET Power Inc. (NYSE: NPWR, NPWR.WS) between June 9, 2023 and March 7, 2025, both dates inclusive (the ...
Wed, 30 Apr 2025 15:12:00 GMT WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential state and federal law claims on behalf of purchasers of Nike-themed non-fungible tokens ("NFTs"), crypto ...
Sun, 27 Apr 2025 18:00:00 GMT New York, New York-- (Newsfile Corp. - April 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Pony ...
Wed, 23 Apr 2025 17:00:00 GMT New York, New York--(Newsfile Corp. - May 7, 2025) - WHY: Rosen Law Firm, a global investor ... On this news, Backblaze stock fell 2.1% on April 24, 2025. WHY ROSEN LAW: We encourage investors to ...
Thu, 17 Apr 2025 17:00:00 GMT WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all persons or entities that: (1) sold or otherwise disposed of the publicly ...
